Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.56% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.52B.
Undervalued
The company’s latest PE is 30.26, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 69.61M shares, increasing 5.73% quarter-over-quarter.
Held by Lee Ainslie
Star Investor Lee Ainslie holds 787.27K shares of this stock.